LISTSERV
- Search Archive
- Browse Archive
SURVEYS
- View Surveys
- Suggest A Survey
- View Suggested Surveys
MEMBER INFO
- Become Member
- Login
RESOURCES
- IDSA Homepage
- Presentations &
Publications
- Conferences & Announcements
|
News In the Literature Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America In 1995, the CDC granted a Cooperative Agreement Program award to the Infectious Diseases Society of America (IDSA) to develop a provider-based emerging infections sentinel network: the Emerging Infections Network (IDSA EIN). During the past decade, the IDSA EIN has evolved into a flexible sentinel network composed of over 1,100 infectious disease specialists primarily from North America, with some global members. The overarching goal of the EIN is to assist CDC and other public health authorities with surveillance for emerging infectious diseases and related phenomena. The specific goals of the EIN are to:
|